MicroAlgo Inc. MLGO
3.31
0.11
3.44%
as of 25 Sep
- Market cap
- $35.0M
- P/E
- 0.0×
Follow MLGO
| Jun '25 | Jun '24 | Dec '23 | Jun '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 |
+8 more quarters Free account |
P/S ratio |
— | — | — | 4,854.98 | |
P/FCF ratio |
— | — | — | 0.00 | |
P/Operating CF |
— | — | — | (158,886.96) | |
P/B ratio |
— | — | — | 10,138.69 | |
Price to Tangible BV |
— | — | — | 13,700.12 | |
EV/Sales |
— | — | — | 4,854.83 | |
EV/EBITDA |
— | — | — | 0.00 | |
EV/Operating CF |
— | — | — | (140,031.77) | |
EV/FCF |
— | — | — | (131,112.14) | |
Quick Ratio |
32.30 | 2.33 | — | 4.26 | |
Current Ratio |
33.06 | 3.55 | — | 4.81 | |
Net Debt/EBITDA |
0.00 | 0.00 | — | 12.79 | |
Debt/Assets |
1.27% | 21.34% | 0.00% | 1.71% | |
Debt/Equity |
0.01 | 0.30 | — | 0.02 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 2.10 | |
Operating CF/Net income |
0.00 | 0.00 | — | 0.93 | |
Capex/Depreciation |
0.00 | (0.01) | — | 42.32 | |
Research and Development Expense of Revenue |
— | — | — | 39.99% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 0.83% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.22 | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Graham Net Nets |
— | — | — | 0.00 | |
Graham Number |
— | — | — | 0.00 | |
Earnings Yield |
— | — | — | (8.25%) | |
Free Cash Flow Yield |
— | — | — | 0.00% | |
Revenue per Share |
— | — | — | 0.46 | |
Operating CF per Share |
0.00 | 0.00 | — | (0.09) | |
Capex per Share |
— | 0.00 | — | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | — | (0.08) | |
Cash per Share |
0.00 | 0.00 | — | 0.44 | |
Shareholders Equity per Share |
0.00 | 0.00 | — | 1.37 | |
Interest Debt per Share |
0.00 | 0.00 | — | 0.00 | |
Book value per Share |
0.00 | 0.00 | — | 1.37 | |
Free Cash Flow |
4.35 | (0.71) | — | (3.72) | |
Working Capital |
320.53 | 77.13 | — | 44.26 | |
Capital Expenditures |
— | 0.00 | — | 0.11 | |
Net Current Asset Value |
320.47 | 77.07 | — | 44.01 | |
EV/EBIT |
— | — | — | 0.00 | |
Capex to Sales |
— | 0.00 | — | (0.01) | |
Net Profit Margin |
— | — | — | (20.23%) | |
Price to Operating Income |
— | — | — | 0.00 | |
| Other line items | |||||
Average Receivables |
3.23 | 5.12 | — | — | |
Average Payables |
2.15 | 2.02 | — | — | |
Average Assets |
203.22 | 89.84 | 24.08 | 59.58 | |
Average Common Equity |
193.89 | 37.01 | — | 28.47 |
Columns are period end dates